592 related articles for article (PubMed ID: 21618684)
1. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
Taner CB; Bulatao IG; Keaveny AP; Willingham DL; Pungpapong S; Perry DK; Rosser BG; Harnois DM; Aranda-Michel J; Nguyen JH
Liver Transpl; 2011 Jun; 17(6):641-9. PubMed ID: 21618684
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts.
Hernandez-Alejandro R; Croome KP; Quan D; Mawardi M; Chandok N; Dale C; McAlister V; Levstik MA; Wall W; Marotta P
Transplantation; 2011 Sep; 92(6):686-9. PubMed ID: 21832962
[TBL] [Abstract][Full Text] [Related]
4. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors.
Taner CB; Bulatao IG; Willingham DL; Perry DK; Sibulesky L; Pungpapong S; Aranda-Michel J; Keaveny AP; Kramer DJ; Nguyen JH
Liver Transpl; 2012 Jan; 18(1):100-11. PubMed ID: 21837741
[TBL] [Abstract][Full Text] [Related]
5. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation following donation after cardiac death: an analysis using matched pairs.
Pine JK; Aldouri A; Young AL; Davies MH; Attia M; Toogood GJ; Pollard SG; Lodge JP; Prasad KR
Liver Transpl; 2009 Sep; 15(9):1072-82. PubMed ID: 19718634
[TBL] [Abstract][Full Text] [Related]
7. Similar liver transplantation survival with selected cardiac death donors and brain death donors.
Dubbeld J; Hoekstra H; Farid W; Ringers J; Porte RJ; Metselaar HJ; Baranski AG; Kazemier G; van den Berg AP; van Hoek B
Br J Surg; 2010 May; 97(5):744-53. PubMed ID: 20393979
[TBL] [Abstract][Full Text] [Related]
8. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of donation after cardiac death liver allografts from a single center.
Nguyen JH; Bonatti H; Dickson RC; Hewitt WR; Grewal HP; Willingham DL; Harnois DM; Schmitt TM; Machicao VI; Ghabril MS; Keaveny AP; Aranda-Michel J; Satyanarayana R; Rosser BG; Hinder RA; Steers JL; Hughes CB
Clin Transplant; 2009; 23(2):168-73. PubMed ID: 19220366
[TBL] [Abstract][Full Text] [Related]
10. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
11. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of hepatitis C infection after liver transplantation.
Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience.
Grewal HP; Willingham DL; Nguyen J; Hewitt WR; Taner BC; Cornell D; Rosser BG; Keaveny AP; Aranda-Michel J; Satyanarayana R; Harnois D; Dickson RC; Kramer DJ; Hughes CB
Liver Transpl; 2009 Sep; 15(9):1028-35. PubMed ID: 19718636
[TBL] [Abstract][Full Text] [Related]
14. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool.
Selck FW; Grossman EB; Ratner LE; Renz JF
Ann Surg; 2008 Oct; 248(4):599-607. PubMed ID: 18936573
[TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression.
Toniutto P; Minisini R; Fabris C; De Feo T; Marangoni F; Burlone M; Avellini C; Bitetto D; Fornasiere E; Fumolo E; Baccarani U; Pirisi M
Clin Transplant; 2009; 23(2):184-90. PubMed ID: 19210526
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting graft survival after liver transplantation from donation after cardiac death donors.
Lee KW; Simpkins CE; Montgomery RA; Locke JE; Segev DL; Maley WR
Transplantation; 2006 Dec; 82(12):1683-8. PubMed ID: 17198260
[TBL] [Abstract][Full Text] [Related]
17. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.
Townsend SA; Monga MA; Nightingale P; Mutimer D; Elsharkawy AM; Holt A
Transplant Proc; 2017 Nov; 49(9):2129-2134. PubMed ID: 29149973
[TBL] [Abstract][Full Text] [Related]
19. Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival.
Doyle MB; Anderson CD; Vachharajani N; Lowell JA; Shenoy S; Lisker-Melman M; Korenblat K; Crippin JS; Chapman WC
Arch Surg; 2008 Jul; 143(7):679-85; discussion 685. PubMed ID: 18645111
[TBL] [Abstract][Full Text] [Related]
20. How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?
Uemura T; Nikkel LE; Hollenbeak CS; Ramprasad V; Schaefer E; Kadry Z
Transpl Int; 2012 Jun; 25(6):671-9. PubMed ID: 22487509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
